China Reform Holdings Leads $101M Round In Chinese Precision Medicine Firm 3D Medicines

Login to View

China Reform Holdings Co., Ltd. has led a RMB670 million (US$101 million) new funding round in 3D Medicines, a Chinese healthcare firm developing precision medicine for cancer treatment.

Continue reading with a China Money Network subscription

Join Now

Already have an account or paid subscription? Log in